Skip to content

Insider · CIK 0001871700

Martha Shadan

director

Files at LMAT (LEMAITRE VASCULAR INC), CVRX (CVRx, Inc.). First filing Nov 15, 2024, latest Nov 15, 2024.

In brief

Martha Shadan files SEC Form 4 as director at LMAT (LEMAITRE VASCULAR INC), and also at CVRX (CVRx, Inc.). Since Nov 15, 2024, Martha Shadan has reported 0 open-market buys worth $0 and 1 open-market sell worth $152k, the latest filed on Nov 15, 2024.

A track record needs three past buys with six months of prices behind them; Martha Shadan has 0, so none is measured yet.

The newest scored trade: sold $152k of LMAT on Nov 13, 2024, filed Nov 15, 2024, scored 46 (moderate).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $152k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

LMAT: LEMAITRE VASCULAR INC

LMATOct 9, 2026 · close 80.69

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
46Moderate
LMATsell 3
LEMAITRE VASCULAR INC
$152k
1,466 shares
-53%-

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Nov 13, 2024 LMAT
LEMAITRE VASCULAR INC
1,466
0.01% of outstanding
$152kNov 13, 2024none

Transactions

The newest 50 of 71 rows this insider has filed.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 3, 2026LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+1$0.00$0635 d ago
Sep 3, 2026LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+1$0.00$0635 d ago
Sep 3, 2026LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+1$0.00$0535 d ago
Sep 3, 2026LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+1$0.00$0535 d ago
Sep 3, 2026LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+2$0.00$0435 d ago
Jun 4, 2026LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+0$0.00$05Jun 5, 2026
Jun 4, 2026LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+1$0.00$05Jun 5, 2026
Jun 4, 2026LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+1$0.00$04Jun 5, 2026
Jun 4, 2026LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+1$0.00$04Jun 5, 2026
Jun 4, 2026LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+1$0.00$03Jun 5, 2026
Jun 1, 2026CVRX
CVRx, Inc.
AGrant or award
Common Stock
+8,720$0.00$08,720Jun 3, 2026
Jun 1, 2026CVRX
CVRx, Inc.
AGrant or award
Stock Option (right to buy)derivative
+11,182$0.00$011,182Jun 3, 2026
Mar 26, 2026LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+0$0.00$05Mar 30, 2026
Mar 26, 2026LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+0$0.00$04Mar 30, 2026
Mar 26, 2026LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+1$0.00$04Mar 30, 2026
Mar 26, 2026LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+1$0.00$04Mar 30, 2026
Mar 26, 2026LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+1$0.00$01Mar 30, 2026
Feb 26, 2026LMAT
LEMAITRE VASCULAR INC
AGrant or award
Common Stock
+476$0.00$02,961Mar 2, 2026
Feb 26, 2026LMAT
LEMAITRE VASCULAR INC
MOption exercise
Common Stock
+1$0.00$02,962Mar 2, 2026
Feb 26, 2026LMAT
LEMAITRE VASCULAR INC
MOption exercise
Dividend Equivalent Rightsderivative
-1$0.00$03Mar 2, 2026
Dec 12, 2025LMAT
LEMAITRE VASCULAR INC
MOption exercise
Common Stock
+5$0.00$02,480Dec 15, 2025
Dec 12, 2025LMAT
LEMAITRE VASCULAR INC
MOption exercise
Common Stock
+5$0.00$02,485Dec 15, 2025
Dec 12, 2025LMAT
LEMAITRE VASCULAR INC
MOption exercise
Dividend Equivalent Rightsderivative
-5$0.00$00Dec 15, 2025
Dec 12, 2025LMAT
LEMAITRE VASCULAR INC
MOption exercise
Dividend Equivalent Rightsderivative
-5$0.00$00Dec 15, 2025
Dec 10, 2025LMAT
LEMAITRE VASCULAR INC
AGrant or award
Common Stock
+533$0.00$02,475Dec 11, 2025
Dec 10, 2025LMAT
LEMAITRE VASCULAR INC
AGrant or award
Stock Option (Right to Buy)derivative
+3,431$0.00$03,431Dec 11, 2025
Dec 8, 2025LMAT
LEMAITRE VASCULAR INC
MOption exercise
Common Stock
+2$0.00$01,939Dec 10, 2025
Dec 8, 2025LMAT
LEMAITRE VASCULAR INC
MOption exercise
Common Stock
+3$0.00$01,942Dec 10, 2025
Dec 8, 2025LMAT
LEMAITRE VASCULAR INC
MOption exercise
Dividend Equivalent Rightsderivative
-2$0.00$04Dec 10, 2025
Dec 8, 2025LMAT
LEMAITRE VASCULAR INC
MOption exercise
Dividend Equivalent Rightsderivative
-3$0.00$04Dec 10, 2025
Dec 6, 2025LMAT
LEMAITRE VASCULAR INC
MOption exercise
Common Stock
+1$0.00$01,937Dec 8, 2025
Dec 4, 2025LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+0$0.00$07Dec 8, 2025
Dec 4, 2025LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+0$0.00$06Dec 8, 2025
Dec 4, 2025LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+1$0.00$06Dec 8, 2025
Dec 4, 2025LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+1$0.00$07Dec 8, 2025
Dec 4, 2025LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+1$0.00$04Dec 8, 2025
Dec 6, 2025LMAT
LEMAITRE VASCULAR INC
MOption exercise
Dividend Equivalent Rightsderivative
-1$0.00$03Dec 8, 2025
Sep 4, 2025LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+0$0.00$07Sep 8, 2025
Sep 4, 2025LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+0$0.00$06Sep 8, 2025
Sep 4, 2025LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+1$0.00$05Sep 8, 2025
Sep 4, 2025LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+1$0.00$06Sep 8, 2025
Sep 4, 2025LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+1$0.00$03Sep 8, 2025
Jun 3, 2025CVRX
CVRx, Inc.
AGrant or award
Stock Option (right to buy)derivative
+19,554$0.00$019,554Jun 5, 2025
May 29, 2025LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+0$0.00$06Jun 2, 2025
May 29, 2025LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+0$0.00$05Jun 2, 2025
May 29, 2025LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+1$0.00$05Jun 2, 2025
May 29, 2025LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+1$0.00$05Jun 2, 2025
May 29, 2025LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+1$0.00$02Jun 2, 2025
Mar 27, 2025LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+0$0.00$06Mar 31, 2025
Mar 27, 2025LMAT
LEMAITRE VASCULAR INC
AGrant or award
Dividend Equivalent Rightsderivative
+0$0.00$05Mar 31, 2025
50 of 71 rows shown.

Questions about Martha Shadan

Answered from the filings on this page, as of the latest one.

Is Martha Shadan buying or selling?

Not in the last 12 months. Martha Shadan's latest open-market trade on SEC Form 4 was sold $152k of LMAT on Nov 13, 2024.

How did Martha Shadan's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Martha Shadan has 0.

Where does Martha Shadan file Form 4?

Martha Shadan has filed Form 4 at LMAT (LEMAITRE VASCULAR INC); CVRX (CVRx, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Martha Shadan: insider trades and track record | InsiderTell